News Photocure ASA

Equities

PHO

NO0010000045

Real-time Oslo Bors Other stock markets 09:11:13 2024-04-26 am EDT			5-day change	1st Jan Change
55.3 ^NOK	+1.65%		+0.91%	-17.95%

Apr. 08	Photocure ASA Announces its Participation in the Congress, and Two Abstract Presentations at the 2024 European Association of Urology Congress in Paris, France	CI
Mar. 28	Photocure ASA Announces the Publication of the Study Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Photocure ASA - Share option grant	Apr. 25	AQ
Photocure ASA - European Association of Urology 2024 congress features new data on modern technology use in bladder cancer care	Apr. 09	AQ
Photocure ASA Announces its Participation in the Congress, and Two Abstract Presentations at the 2024 European Association of Urology Congress in Paris, France	Apr. 08	CI
Photocure to Participate in the 23rd Annual Needham Virtual Healthcare Conference	Apr. 08	AQ
European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care	Apr. 08	AQ
Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference	Apr. 05	AQ
New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy	Mar. 28	AQ
Photocure ASA Announces the Publication of the Study Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy	Mar. 28	CI
Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting	Mar. 18	AQ
Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO	Feb. 23	AQ
Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO	Feb. 23	AQ
Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN	Feb. 22	AQ
Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN	Feb. 22	AQ
Transcript : Photocure ASA, Q4 2023 Earnings Call, Feb 21, 2024	Feb. 21
Photocure ASA: Results for the fourth quarter of 2023	Feb. 21	AQ
Photocure ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 21	CI
Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2023 financial results	Feb. 19	AQ
Photocure Partner Asieris presented clinical trial and real-world data on Hexvix in China at ASCO GU 2024	Jan. 29	AQ
Photocure ASA - Share option grant	Dec. 21	AQ
Photocure : Partner Asieris to present unpublished clinical trial and real-world data on Hexvix in China at ASCO GU 2024	Dec. 15	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Photocure ASA

Equities

PHO

NO0010000045

Summary

Filters